These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8424888)

  • 21. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination.
    Zhang S; Liang X; Danielsen M
    Mol Endocrinol; 1996 Jan; 10(1):24-34. PubMed ID: 8838142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
    Pakdel F; Reese JC; Katzenellenbogen BS
    Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining a minimal estrogen receptor DNA binding domain.
    Mader S; Chambon P; White JH
    Nucleic Acids Res; 1993 Mar; 21(5):1125-32. PubMed ID: 8385312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The analysis of chimeric human/rainbow trout estrogen receptors reveals amino acid residues outside of P- and D-boxes important for the transactivation function.
    Petit FG; Valotaire Y; Pakdel F
    Nucleic Acids Res; 2000 Jul; 28(14):2634-42. PubMed ID: 10908317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active, interactive, and inactive steroid receptor mutants.
    Lanz RB; Hug M; Gola M; Tallone T; Wieland S; Rusconi S
    Steroids; 1994 Feb; 59(2):148-52. PubMed ID: 8191545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure, thermodynamics and cooperativity of the glucocorticoid receptor DNA-binding domain in complex with different response elements. Molecular dynamics simulation and free energy perturbation studies.
    Eriksson MA; Nilsson L
    J Mol Biol; 1995 Oct; 253(3):453-72. PubMed ID: 7473727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function of N-terminal transactivation domain of the estrogen receptor requires a potential alpha-helical structure and is negatively regulated by the A domain.
    Métivier R; Petit FG; Valotaire Y; Pakdel F
    Mol Endocrinol; 2000 Nov; 14(11):1849-71. PubMed ID: 11075817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant.
    Ramos RA; Meilandt WJ; Wang EC; Firestone GL
    FASEB J; 1999 Jan; 13(1):169-80. PubMed ID: 9872941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid receptor transcriptional synergy is potentiated by disruption of the DNA-binding domain dimer interface.
    Liu W; Wang J; Yu G; Pearce D
    Mol Endocrinol; 1996 Nov; 10(11):1399-406. PubMed ID: 8923466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative differences in androgen and glucocorticoid receptor DNA binding properties contribute to receptor-selective transcriptional regulation.
    Rundlett SE; Miesfeld RL
    Mol Cell Endocrinol; 1995 Mar; 109(1):1-10. PubMed ID: 7789609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA-binding specificity of mutant glucocorticoid receptor DNA-binding domains.
    Zilliacus J; Wright AP; Norinder U; Gustafsson JA; Carlstedt-Duke J
    Ann N Y Acad Sci; 1993 Jun; 684():253-5. PubMed ID: 8317845
    [No Abstract]   [Full Text] [Related]  

  • 32. Determinants for DNA-binding site recognition by the glucocorticoid receptor.
    Zilliacus J; Wright AP; Norinder U; Gustafsson JA; Carlstedt-Duke J
    J Biol Chem; 1992 Dec; 267(35):24941-7. PubMed ID: 1459998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation.
    Banuelos J; Shin SC; Lu NZ
    Steroids; 2015 Apr; 96():115-20. PubMed ID: 25676786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.
    Verrijdt G; Haelens A; Schoenmakers E; Rombauts W; Claessens F
    Biochem J; 2002 Jan; 361(Pt 1):97-103. PubMed ID: 11742533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimerization characteristics of the DNA- and steroid-binding domains of the androgen receptor.
    Nemoto T; Ohara-Nemoto Y; Shimazaki S; Ota M
    J Steroid Biochem Mol Biol; 1994 Sep; 50(5-6):225-33. PubMed ID: 7918108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains.
    Schoenmakers E; Alen P; Verrijdt G; Peeters B; Verhoeven G; Rombauts W; Claessens F
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):515-21. PubMed ID: 10417312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metal-dependent folding and stability of nuclear hormone receptor DNA-binding domains.
    Low LY; Hernández H; Robinson CV; O'Brien R; Grossmann JG; Ladbury JE; Luisi B
    J Mol Biol; 2002 May; 319(1):87-106. PubMed ID: 12051939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrimination of DNA response elements for thyroid hormone and estrogen is dependent on dimerization of receptor DNA binding domains.
    Hirst MA; Hinck L; Danielsen M; Ringold GM
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5527-31. PubMed ID: 1608965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.